Reported Reactions

Devices › Counter, differential cell

Device brand name · Counter differential cell

Coulter Act Diff Analyzer: medical device reports filed with FDA

480 reports name it, 2008–2016. Manufacturer given most often on reports: Beckman Coulter. Product code GKZ.

480
device reports naming the brand
0% of all MAUDE reports · about 26 a year
0
reports, 12 months to August 2026
0 in the 12 months before
100%
classified as malfunction
95.7% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 480 reports that name the brand "Coulter Act Diff Analyzer" (counter differential cell), received between March 2008 and November 2016; the manufacturer given most often on reports is Beckman Coulter. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%); across all counter, differential cell reports (product code GKZ) death is recorded in 0.1% and malfunction in 95.7%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are fluid/blood leak (51%), leak/splash (27.7%) and low test results (6%). The patient problems coded most often are not applicable, venipuncture and test result. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Coulter Act Diff Analyzer was received in the five years to August 2026; the latest was received in November 2016.

By year received

0551092008: 720082009: 420092010: 1020102011: 3820112012: 8620122013: 7220132014: 10920142015: 10420152016: 502016

Event type and report source

Event type, as classified on the report

Death0%0
Injury0%0
Malfunction100%480
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%480
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 23,441 reports carrying product code GKZ. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Fluid/blood leak24551%29.2%
Leak/splashthe device leaked13327.7%13.8%
Low test results296%16.5%
Device displays incorrect message214.4%6.1%
Device operates differently than expectedthe device behaved unexpectedly173.5%3.1%
Incorrect or inadequate test results173.5%8.9%
High test results112.3%5.3%
Chemical spillage61.3%0.5%
Overfill61.3%0.4%
Excess flow or over-infusion51%0.2%
Device alarm system40.8%0.8%
Incorrect, inadequate or imprecise result or readings40.8%8.6%
Output problem40.8%1%
Infusion or flow problema problem with flow or infusion30.6%0.1%
Complete blockage20.4%0.2%
Device slipped20.4%0.2%
Kinkedthe tube or line kinked20.4%0.1%
Noise, audible20.4%0.2%
Occlusion within devicethe device blocked20.4%0.1%
Smoking20.4%1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Not applicable7615.8%
Venipuncture20.4%
Test result10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCoulter Act Diff AnalyzerProduct code GKZAll MAUDE reports
Reports48023,44126,136,888
Share of that pool—2%0%
Classified as death, per 1,000 reports019
Classified as injury0%1.4%36.2%
Classified as malfunction100%95.7%62.3%
Filed by the manufacturer100%99.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code GKZ

BrandReportsLatest 12 monthsClassified as death
Coulter Lh 750 Hematology Analyzer2,73000%
Cell-Dyn Emerald Cleaner2,22900%
Coulter Lh 500 Hematology Analyzer2,01600%
Coulter Lh 780 Hematology Analyzer1,61400%
Unicel Dxh 800 Coulter Cellular Analysis System1,59100%
Fc 500 Flow Cytometer1,19800%
Coulter Hmx Hematology Analyzer With Autoloader75500%
Cell-Dyn Sapphire Analyzer63600%
Coulter Act Diff 2 Analyzer53600%
Cell-Dyn Wbc Reagent A51900%
Cell-Dyn Ruby Analyzer45800.7%
Coulter Ac T Diff Analyzer44900%
Coulter Ac T Diff 2 Analyzer42500%
Cell-Dyn 1800 Analyzer37700%
Coulter Lh750 Hematology Analyzer34700%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Coulter Act Diff Analyzer reports

How many FDA reports name Coulter Act Diff Analyzer?

480 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

fluid/blood leak (51%), leak/splash (27.7%), low test results (6%), device displays incorrect message (4.4%) and device operates differently than expected (3.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Coulter Act Diff Analyzer was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.